Biodistribution of 111In-DTPA-D-Phe1-octreotide in tumor-bearing nude mice:: influence of amount injected and route of administration

被引:29
作者
Bernhardt, P [1 ]
Kölby, L
Johanson, V
Nilsson, O
Ahlman, H
Forssell-Aronsson, E
机构
[1] Gothenburg Univ, Sahlgrens Univ Hosp, Dept Radiat Phys, SE-41345 Gothenburg, Sweden
[2] Gothenburg Univ, Sahlgrens Univ Hosp, Dept Pathol, SE-41345 Gothenburg, Sweden
[3] Gothenburg Univ, Sahlgrens Univ Hosp, Dept Surg, SE-41345 Gothenburg, Sweden
关键词
biodistribution; In-111-DTPA-D-Phe(1)-octreotide; carcinoid; nude mice; administration;
D O I
10.1016/S0969-8051(02)00417-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In nude mice carrying the human carcionoid GOT1 different amounts of In-111-DTPA-Phe(1)-octreotide and routes of administration were studied in relation to uptake in tumor and normal organs. The relative organ uptake varied with given amount; highest in tumor after 0.1 and 1 mug and lowest in muscle, heart and blood after 0.1 mug. The uptake decreased in lungs and spleen with higher amounts of In-111-DTPA-Phe1-octreotide. In all organs studied the tumor-to-normal-tissue activity concentration ratio was maximal at 0.1 and 1 mug, but route of administration influenced the uptake only little. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:253 / 260
页数:8
相关论文
共 26 条
  • [1] CLINICAL EFFICACY OF OCTREOTIDE SCINTIGRAPHY IN PATIENTS WITH MIDGUT CARCINOID-TUMORS AND EVALUATION OF INTRAOPERATIVE SCINTILLATION DETECTION
    AHLMAN, H
    WANGBERG, B
    TISELL, LE
    NILSSON, O
    FJALLING, M
    FORSSELLARONSSON, E
    [J]. BRITISH JOURNAL OF SURGERY, 1994, 81 (08) : 1144 - 1149
  • [2] Andersson P, 1996, J NUCL MED, V37, P2002
  • [3] ANDERSSON P, 1999, 6 INT RAD DOS S P HE, P127
  • [4] INVIVO APPLICATION OF [IN-111-DTPA-D-PHE1]-OCTREOTIDE FOR DETECTION OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS IN RATS
    BAKKER, WH
    KRENNING, EP
    REUBI, JC
    BREEMAN, WAP
    SETYONOHAN, B
    DEJONG, M
    KOOIJ, PPM
    BRUNS, C
    VANHAGEN, PM
    MARBACH, P
    VISSER, TJ
    PLESS, J
    LAMBERTS, SWJ
    [J]. LIFE SCIENCES, 1991, 49 (22) : 1593 - 1601
  • [5] Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector
    Benjegård, SA
    Forssell-Aronsson, E
    Wängberg, B
    Skånberg, J
    Nilsson, O
    Ahlman, H
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) : 1456 - 1462
  • [6] Biokinetics of 111In-DTPA-D-Phe1-octreotide in nude mice transplanted with a human carcinoid tumor
    Bernhardt, P
    Kölby, L
    Johanson, V
    Benjegård, SA
    Nilsson, O
    Ahlman, H
    Forssell-Aronsson, E
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (01) : 67 - 73
  • [7] Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney
    Boerman, OC
    Oyen, WJG
    Corstens, FHM
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10): : 1447 - 1449
  • [8] BREEMAN WAP, 1995, J NUCL MED, V36, P623
  • [9] End-stage renal disease after treatment with 90Y-DOTATOC
    Cybulla, M
    Weiner, SM
    Otte, A
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) : 1552 - 1554
  • [10] de Jong M, 2002, J NUCL MED, V43, P617